Evidence map›Paper›PMID 33912131›Full record

ReviewFrontiers in endocrinology2021

Endocrine Disruptor Compounds-A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy?

John E Schjenken, Ella S Green, Tenuis S Overduin, Chui Yan Mah, Darryl L Russell, Sarah A Robertson

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Guardians under Siege: Exploring Pollution's Effects on Human Immunity.International journal of molecular sciences · 2024
    Review
  16. Breast Cancer Exposomics.Life (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John E SchjenkenAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Ella S GreenAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Tenuis S OverduinAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Chui Yan MahAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Darryl L RussellAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Sarah A RobertsonAdelaide Medical School and The Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
University of Adelaide · AUHunter Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine disrupting compounds (EDCs) are prevalent and ubiquitous in our environment and have substantial potential to compromise human and animal health. Amongst the chronic health conditions associated with EDC exposure, dysregulation of reproductive function in both females and males is prominent. Human epidemiological studies demonstrate links between EDC exposure and infertility, as well as gestational disorders including miscarriage, fetal growth restriction, preeclampsia, and preterm birth. Animal experiments show EDCs administered during gestation, or to either parent prior to conception, can interfere with gamete quality, embryo implantation, and placental and fetal development, with consequences for offspring viability and health. It has been presumed that EDCs operate principally through disrupting hormone-regulated events in reproduction and fetal development, but EDC effects on maternal immune receptivity to pregnancy are also implicated. EDCs can modulate both the innate and adaptive arms of the immune system, to alter inflammatory responses, and interfere with generation of regulatory T (Treg) cells that are critical for pregnancy tolerance. Effects of EDCs on immune cells are complex and likely exerted by both steroid hormone-dependent and hormone-independent pathways. Thus, to better understand how EDCs impact reproduction and pregnancy, it is imperative to consider how immune-mediated mechanisms are affected by EDCs. This review will describe evidence that several EDCs modify elements of the immune response relevant to pregnancy, and will discuss the potential for EDCs to disrupt immune tolerance required for robust placentation and optimal fetal development.

Indexed as

AnimalsEndocrine DisruptorsFemaleFetal DevelopmentHumansImmune ToleranceInfant, NewbornInflammationMalePregnancyPregnancy ComplicationsEndocrine Disruptorsdevelopmental origins of health and diseaseendocrine disrupting compoundsfetal tolerancepregnancyreproductionreproductive immunology

Identifiers

PMID33912131
PMCPMC8072457
OpenAlexW3152501313

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.